/

/

Share this news:

Share this news:

Longevity Gene from Centenarians Reverses Heart Aging in Progeria Models

Longevity Gene from Centenarians Reverses Heart Aging in Progeria Models

Scientists have discovered that a gene variant found in supercentenarians can restore heart function and slow aging symptoms in models of Progeria, a rare disease causing rapid aging in children.

Concept illustration featuring DNA strands and an hourglass, symbolizing the link between genetics and longevity.

Source:

ScienceDaily

Breakthrough in Genetic Research

Researchers have identified a gene variant found in people aged over 100 that can reverse heart aging and relieve symptoms of Hutchinson-Gilford Progeria Syndrome (HGPS), a rare disorder that causes children to experience rapid aging. The study, led by scientists at the University of Bristol and IRCCS MultiMedica, marks a significant step in age-related disease research (ScienceDaily).

HGPS is caused by a mutation in the LMNA gene, resulting in the buildup of a toxic protein, progerin, which damages heart and blood vessel cells. Most patients succumb to heart complications as teenagers.

Keep up with the story. Subscribe to the PR+ free daily newsletter

Scientific image from a study related to genetic research on aging.

Source:

Wiley Online Library

How the Longevity Gene Works

Mechanism and Comparison to Existing Treatment

  • Gene therapy using the supercentenarian variant restored heart function in Progeria cell and animal models.

  • Unlike drugs such as lonafarnib, which focus on lowering progerin levels, this gene strengthens natural cell defenses without directly removing the toxic protein (Bioengineer.org).

  • This is the first evidence that a gene associated with extreme longevity can counteract rapid cardiovascular aging due to Progeria (Phys.org).

Therapeutic Potential

  • Future therapies may draw from centenarian biology for not just rare diseases, but general aging and age-related heart disease.

  • Researchers are considering delivery systems using protein or RNA based on these genetic findings (Nature).

High-quality modern illustration showing cellular biology related to longevity research.

Source:

VitaDAO

Looking Ahead: Impacts and Implications

Supercentenarians Provide Clues

  • Studies on individuals like Maria Branyas Morera have shown that rare genetic variants can protect against age-related illness and keep inflammation low (SciTechDaily).

  • This discovery suggests aging and disease may not always go hand in hand if certain protective genes are present (HealthBookPlus).

What Comes Next?

  1. Further clinical trials in humans are needed before the therapy can be approved for wider use.

  2. Experts believe this opens the door to gene therapies inspired by the biology of the world’s oldest people.

  3. The potential extends far beyond Progeria, possibly transforming approaches to treating age-related cardiovascular diseases.

Looking Ahead: Impacts and Implications

Supercentenarians Provide Clues

  • Studies on individuals like Maria Branyas Morera have shown that rare genetic variants can protect against age-related illness and keep inflammation low (SciTechDaily).

  • This discovery suggests aging and disease may not always go hand in hand if certain protective genes are present (HealthBookPlus).

What Comes Next?

  1. Further clinical trials in humans are needed before the therapy can be approved for wider use.

  2. Experts believe this opens the door to gene therapies inspired by the biology of the world’s oldest people.

  3. The potential extends far beyond Progeria, possibly transforming approaches to treating age-related cardiovascular diseases.

How does the longevity gene specifically reverse heart aging in Progeria models?

The gene variant boosts cellular defenses and resilience, improving heart function and reducing tissue damage without directly removing the toxic progerin protein.

How does the longevity gene specifically reverse heart aging in Progeria models?

The gene variant boosts cellular defenses and resilience, improving heart function and reducing tissue damage without directly removing the toxic progerin protein.

How does the longevity gene specifically reverse heart aging in Progeria models?

The gene variant boosts cellular defenses and resilience, improving heart function and reducing tissue damage without directly removing the toxic progerin protein.

What are the potential side effects of using the longevity gene in human treatments?

What are the potential side effects of using the longevity gene in human treatments?

What are the potential side effects of using the longevity gene in human treatments?

How does the longevity gene compare to other treatments currently available for Progeria?

How does the longevity gene compare to other treatments currently available for Progeria?

How does the longevity gene compare to other treatments currently available for Progeria?

Can the longevity gene be used to treat other age-related diseases?

Can the longevity gene be used to treat other age-related diseases?

Can the longevity gene be used to treat other age-related diseases?

What are the next steps in clinical trials for the longevity gene therapy?

What are the next steps in clinical trials for the longevity gene therapy?

What are the next steps in clinical trials for the longevity gene therapy?

Share this news: